1.Targeting castration-resistant prostate cancer with a novel ROR
Jianwei ZHENG ; Junfeng WANG ; Qian WANG ; Hongye ZOU ; Hong WANG ; Zhenhua ZHANG ; Jianghe CHEN ; Qianqian WANG ; Panxia WANG ; Yueshan ZHAO ; Jing LU ; Xiaolei ZHANG ; Songtao XIANG ; Haibin WANG ; Jinping LEI ; Hong-Wu CHEN ; Peiqing LIU ; Yonghong LIU ; Fanghai HAN ; Junjian WANG
Acta Pharmaceutica Sinica B 2020;10(12):2313-2322
Prostate cancer (PCa) patients who progress to metastatic castration-resistant PCa (mCRPC) mostly have poor outcomes due to the lack of effective therapies. Our recent study established the orphan nuclear receptor ROR
Result Analysis
Print
Save
E-mail